EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Enrico Ruffini
Pier Luigi Filosso
Giuliano Maggi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruffini, E.
Right arrow Articles by Maggi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruffini, E.
Right arrow Articles by Maggi, G.
Related Collections
Right arrow Lung - cancer

Eur J Cardiothorac Surg 2002;22:701-707
© 2002 Elsevier Science NL


Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance

Enrico Ruffinia*, Ottavio Renaa, Alberto Oliaroa, Pier Luigi Filossoa, Massimo Bongiovannib, Anna Arslaniana, Esther Papaliaa, Giuliano Maggia

a Department of Thoracic Surgery, University of Torino, 3, Via Genova, 10126 Turin, Italy
b Department of Pathology, University of Torino, 3, Via Genova, 10126 Turin, Italy

Received 4 September 2001; received in revised form 2 August 2002; accepted 5 August 2002.

* Corresponding author. Tel.: +39-11-633-5919; fax: +39-11-696-0170
e-mail: enrico.ruffini{at}unito.it

Objective: To analyze and compare clinico-pathologic characteristics and survival between lung tumors with mixed histologic pattern and our population of resected lung tumors with single histology in the same period. Methods: From January 1993 to December 1999, 1158 patients received resection for lung tumors. Of these, 59 (5.1%) presented a mixed histologic pattern on the surgical specimen. There were 48 men and 11 women (mean age 64 years, range 43–79). Three groups of tumors were identified: adenosquamous carcinoma, combined neuroendocrine+non-neuroendocrine carcinoma (NNEC) and biphasic tumors (epithelial+mesenchymal malignant components) represented by carcinosarcoma and blastoma. The combined neuroendocrine tumors were further divided in small cell lung carcinoma (SCLC)+large cell neuroendocrine carcinoma (LCNEC)/NNEC and other neuroendocrine tumors/NNEC. Clinico-pathologic characteristics, pTNM and survival were analyzed and compared to our population of resected lung tumors with single histology. Results: There were 33 adenosquamous carcinomas, 19 combined SCLC+LCNEC/NNEC, two other neuroendocrine tumors/NNEC and five biphasic tumors (three carcinosarcomas and two blastomas). Among adenosquamous carcinomas, high cell grading (G2 or G3), advanced stage (IIIa or higher) and intratumoral perineural invasion were significantly more evident than in the single histology population. Among combined neuroendocrine/NNEC, high cell grading (G3) and intratumoral vascular invasion were significantly more evident than in the single histology population. Among biphasic tumors, all were at early stages and showed high cell grading (G3). Three-year survival rates were 46% in the single histology group, 28% in the adenosquamous group and 21% in the combined SCLC+LCNEC/NNEC. The difference among the three groups was significant (P=0.013). Median survival of biphasic tumors was 19 months (range 8–37). Conclusions: Lung tumors with mixed histologic pattern are rare tumors. Adenosquamous carcinoma and combined SCLC+LCNEC/NNEC present a more aggressive clinico-pathologic behaviour and reduced survival as compared to the single histology population of resected lung tumors.

Key Words: Mixed lung tumors • Combined lung tumors • Biphasic tumors • Adenosquamous carcinoma • Neuroendocrine tumors • Carcinosarcoma • Blastoma




This article has been cited by other articles:


Home page
Am J Clin PatholHome page
C. A. Moran, S. Suster, D. Coppola, and M. R. Wick
Neuroendocrine Carcinomas of the Lung: A Critical Analysis
Am J Clin Pathol, February 1, 2009; 131(2): 206 - 221.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Fukui, Y. Ohe, K. Tsuta, K. Furuta, H. Sakamoto, T. Takano, H. Nokihara, N. Yamamoto, I. Sekine, H. Kunitoh, et al.
Prospective Study of the Accuracy of EGFR Mutational Analysis by High-Resolution Melting Analysis in Small Samples Obtained from Patients with Non-Small Cell Lung Cancer
Clin. Cancer Res., August 1, 2008; 14(15): 4751 - 4757.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S-P Cheng, T-L Yang, K-M Chang, and C-L Liu
Large cell neuroendocrine carcinoma of the ampulla of Vater with glandular differentiation
J. Clin. Pathol., October 1, 2004; 57(10): 1098 - 1100.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.